What are the appropriate admission orders for a patient experiencing an acute exacerbation of chronic congestive heart failure?

Admission Orders for Acute Exacerbation of Chronic CHF

For patients admitted with acute decompensated heart failure, immediately initiate IV loop diuretics, establish continuous telemetry monitoring, implement daily weights with strict intake/output monitoring, and obtain baseline labs including BNP/NT-proBNP, renal function panel, and electrolytes within the first hours of admission 1.

Immediate Orders (First 24 Hours)

Monitoring

• Continuous cardiac telemetry
• Daily weights (same scale, same time)
• Strict intake and output charting (avoid routine urinary catheter unless specific indication) 1
• Vital signs: pulse, respiratory rate, blood pressure every 4 hours minimum 1
• Consider intra-arterial line if hypotension with persistent symptoms despite treatment 1

Laboratory Studies

• BNP or NT-proBNP at admission (falling levels during hospitalization predict better 6-month outcomes) 1
• Complete metabolic panel: BUN/creatinine, sodium, potassium
• Daily monitoring of renal function and electrolytes during IV diuretic therapy 1
• Troponin, CBC, liver function tests
• TSH if not recently checked
• Consider iron studies (ferritin, transferrin saturation)

Imaging

• Chest X-ray (assess pulmonary congestion, cardiomegaly)
• Echocardiogram if not done recently or clinical change

Therapeutic Interventions

Diuretic Therapy (Cornerstone of ADHF Management)

• IV loop diuretics as primary decongestive therapy 1, 2
• Dose based on home regimen: if on oral diuretics, start with IV dose equivalent to or greater than home dose
• Staged approach based on patient response 2
• Monitor urine output and consider natriuresis-guided therapy 3

Vasodilators

• IV nitroglycerin for patients with hypertension and pulmonary congestion (not hypotensive)
• Contraindicated if systolic BP <90 mmHg

Oxygen/Respiratory Support

• Supplemental oxygen to maintain SpO2 >90%
• Consider non-invasive ventilation (BiPAP/CPAP) for respiratory distress

Activity and Diet

• Sodium restriction: 2 grams daily
• Fluid restriction: 1.5-2 liters daily if hyponatremic
• Activity as tolerated with physical therapy consultation

Intermediate Phase (Days 2-5)

Assess and Address

• Volume status daily: jugular venous pressure, peripheral edema, lung sounds, weight trend
• Hemodynamic stability: blood pressure, heart rate, perfusion
• Renal function trajectory: improving vs. worsening with diuresis 1
• Identify precipitating factors: medication non-adherence, dietary indiscretion, arrhythmia, ischemia, infection, uncontrolled hypertension 4
• Evaluate comorbidities: diabetes, anemia, kidney disease, lung disease, liver disease 4

Medication Optimization

Critical: The day of transition from IV to oral diuretics triggers discharge planning 4

• Initiate or up-titrate guideline-directed medical therapy (GDMT) during stable phase 1, 2:
  • ACE inhibitor/ARB or sacubitril/valsartan (preferred)
  • Beta-blocker (carvedilol, metoprolol succinate, or bisoprolol)
  • Mineralocorticoid receptor antagonist (spironolactone or eplerenone)
  • SGLT2 inhibitor (dapagliflozin or empagliflozin) - now recommended across entire EF spectrum 3

Subspecialty Consultation

• Cardiology consultation for all new-onset HF or unclear etiology 5
• Consider advanced HF/transplant evaluation if refractory symptoms
• Palliative care if unfavorable trajectory or end-stage disease 4

Pre-Discharge Requirements (24 Hours Before Discharge)

Patients are medically fit for discharge when 1:

• Hemodynamically stable for ≥24 hours
• Euvolemic (or near baseline dry weight)
• Established on evidence-based oral medications
• Stable renal function for ≥24 hours

Discharge Checklist

• Medication reconciliation complete - avoid initiating new therapies on discharge day 4
• Patient education provided: disease process, medications, daily weights, dietary restrictions, when to call physician 1
• Caregiver education completed 4
• Follow-up appointments scheduled:
  • Primary care within 7 days 1
  • Cardiology within 14 days 1
• Enrollment in disease management program 1
• Discharge summary accessible to outpatient team with key hospitalization events 4

Common Pitfalls to Avoid

• Inadequate diuresis: Most readmissions occur due to persistent congestion - ensure true euvolemia before discharge
• Premature discharge: Stable for only 12 hours is insufficient; require 24-hour stability 1
• Failure to optimize GDMT: The hospitalization is the opportunity to initiate/uptitrate evidence-based therapies 2
• Ignoring worsening renal function: Daily monitoring prevents dangerous electrolyte abnormalities 1
• Poor discharge planning: Over 80% of patients are readmitted without proper follow-up arrangements 4
• Starting new medications on discharge day: This increases confusion and medication errors 4

High-Risk Features Requiring ICU/Advanced Monitoring

• Cardiogenic shock (hypotension with end-organ hypoperfusion)
• Respiratory failure requiring mechanical ventilation
• Refractory symptoms despite pharmacologic therapy - consider pulmonary artery catheter 1
• Incessant ventricular arrhythmias

The evidence strongly supports a "high-intensity care" strategy with rapid GDMT up-titration and close follow-up after discharge, which improves outcomes 6. The 30-day readmission rate remains 17-22% 2, making meticulous discharge planning with confirmed follow-up arrangements non-negotiable.